CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Benjamin J. Huang,Kassra Taghizadeh,Rhonda E. Ries,Yanling Liu,Pandurang Kolekar,Katherine Tarlock,Erin Crowgey,Kohei Hagiwara,Lisa Wei,Richard Aplenc,Xiaotu Ma,Soheil Meshinchi,Jenny L. Smith,Yi-Cheng Wang,Amanda R. Leonti,Robert Gerbing,Scott N. Furlan,Timothy I. Shaw,Todd M. Cooper,Alan S. Gamis,E. Anders Kolb,Jason E. Farrar,Timothy Triche,Todd A. Alonzo
DOI: https://doi.org/10.1182/bloodadvances.2021004965
IF: 7.642
2021-11-30
Blood Advances
Abstract:Key Points CBFB-MYH11 transcripts and KIT mutations predict relapse in AML. High-risk CBFB-MYH11 transcripts are associated with distinct transcriptional landscapes and upregulation of early hematopoiesis genes.
hematology
What problem does this paper attempt to address?